Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Thanks! [Regulatives / Guidelines]

posted by fno – Belgium, 2020-01-23 14:48 (611 d 16:23 ago) – Posting: # 21084
Views: 1,920
(edited by fno on 2020-01-23 16:16)

—
Kind regards,
Fabrice

Complete thread:

FDA: required BE between early phase and Phase 3 formulations? fno 2020-01-22 15:38 [Regulatives / Guidelines]
- no BE between early phase and Phase 3 formulations Helmut 2020-01-22 16:15
  - no BE between early phase and Phase 3 formulations fno 2020-01-22 17:11
    - relax Helmut 2020-01-23 11:59
      - Thanks!fno 2020-01-23 14:48
- FDA: required BE between early phase and Phase 3 formulations? Achievwin 2020-01-27 20:06

Admin contact
21,700 posts in 4,538 threads, 1,542 registered users;
online 5 (0 registered, 5 guests [including 5 identified bots]).
Forum time: Sunday 08:12 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable. Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz